This classifier result and the calibrated score was interpreted as has been described by Capper et al. as supportive of the PXA diagnosis with additional confirmation from the BRAF mutation and homozygous CDKN2A loss [12]. The gene discussed is BRAF; the disease is pleomorphic xanthoastrocytoma.